Promoting Competition
and Investment in the
U.S. Life Sciences Ecosystem
The U.S. life sciences ecosystem depends on mergers and acquisitions (M&A) to bring together the resources, investment and expertise needed to develop and deliver treatments and cures for patients.
FUELING COMPETITION AND INVESTMENT
M&A drives competition and investment across America's life sciences industry.
FACILITATING INNOVATION
Life sciences companies of all sizes engage in M&A to connect innovations with the resources needed to bring them to market.
DRIVING AMERICAN GROWTH, LEADERSHIP
M&A plays a critical role within America’s world-class life sciences industry.
biopharmaceutical companies headquartered in the U.S.
PARTNERS
ABOUT US
PULSE is a national coalition raising awareness about the unique and fundamental role of mergers and acquisitions (M&A) in America’s life sciences industry. M&A enables life sciences companies of all sizes to bring together resources, investment and expertise needed to develop and deliver new treatments and cures. PULSE members represent researchers, manufacturers and leaders of life sciences companies of all sizes that make up a diverse, vibrant life sciences industry across America.
LATEST NEWS
Importance of Life Sciences M&A Amid Rising Interest Rates
Increasingly high bond rates are having important implications for the U.S. life sciences ecosystem – and underscore the role of mergers and acquisitions (M&A) and other pro-competitive partnerships in advancing innovation.
Strengthening American Leadership: M&A Helps Early-Stage Life Science Companies Manufacture in America
Policymakers are increasingly focused on strengthening domestic life sciences manufacturing. A healthy, predictable environment for life sciences M&A should be part of that effort.
Q3 2026 Highlights – Partnership for the U.S. Life Science Ecosystem (PULSE)
PULSE continues to spotlight the unique and fundamental role of mergers and acquisitions (M&A) and other collaborations in supporting America’s innovative life sciences ecosystem.